In this short interview from the BioProcess Theater at BIO 2025 in Boston, AGC Biologics CBO Christoph Winterhalter discusses the rapidly evolving world of complex drug development and the critical factors that drive success for products made using different molecules beyond the traditional antibodies.
He also discusses what builds a strong sponsor–supplier partnership, from transparency to cultural alignment, and how drug sponsors can leverage these relationships to accelerate innovation when developing a product.
The conversation also explores how geopolitical factors are reshaping the global pharmaceutical market, creating both challenges and opportunities for companies seeking speed and flexibility, and options for avoiding costly tariffs.
Watch the interview today: